|

IMVT-1402 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Immunovant Sciences GmbH2

Indications

  • Chronic Cutaneous Lupus Erythematosus1
  • Subacute Cutaneous Lupus Erythematosus1
  • Lupus1
  • Generalized Myasthenia Gravis1
  • Cancer1

Anniston, Alabama1 trial

A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Site Number - 1010

Phase 2

Mobile, Alabama1 trial

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Site Number - 1041

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.